✦ LIBER ✦

A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis

✍ Scribed by Ralph A.H. Stewart; Andrew J. Kerr; Brett R. Cowan; Alistair A. Young; Christopher Occleshaw; A. Mark Richards; Colin Edwards; Gillian A. Whalley; Denis Freidlander; Miles Williams; Robert N. Doughty; Irene Zeng; Harvey D. White

Book ID: 116191402
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 255 KB
Volume: 156
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2008.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk stratification in asymptomatic mode

Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay

✍ Lancellotti, P.; Donal, E.; Magne, J.; Moonen, M.; O'Connor, K.; Daubert, J.-C.; 📂 Article 📅 2010 🏛 BMJ 🌐 English ⚖ 379 KB

Su2091 Results of a Phase II, Randomized

Su2091 Results of a Phase II, Randomized, Double Blind, Controlled Trial of the Efficacy of Active Therapeutic Immunization With TNF-Kinoid in Patients With Moderate to Severe Crohn's Disease With Secondary Resistance to TNFα Antagonist

✍ Dewit, Olivier; Hebuterne, Xavier; Dupas, Jean-Louis; Howaldt, Stefanie M.; Bure 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Safety and efficacy of the novel antieme

Safety and efficacy of the novel antiemetic neurokinin-1 (NK-1) receptor antagonist, casopitant, in women with breast cancer (BC) receiving moderately emetogenic chemotherapy (MEC) – subgroup analysis from a randomized, double-blind, placebo-controlled phase II trial

✍ J. Herrstedt; W. Arpornwirat; I. Albert; V.L. Hansen; R.R. Bandekar; J. Levin; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB